67 related articles for article (PubMed ID: 29480348)
21. [A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder].
Obayashi K; Miki J; Kasai K; Tashiro K; Tsuduki S; Bando S; Ishii G; Suzuki K; Kimura T; Kishimoto K; Egawa S
Hinyokika Kiyo; 2014 Sep; 60(9):443-6. PubMed ID: 25293799
[TBL] [Abstract][Full Text] [Related]
22. Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.
Horiguchi H; Yoneyama T; Hatakeyama S; Tokui N; Sato T; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Narita S; Kawaguchi T; Ohyama C
Med Oncol; 2018 Feb; 35(4):41. PubMed ID: 29480348
[TBL] [Abstract][Full Text] [Related]
23. Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?
Territo A; Fontanet S; Meneghetti I; Gallioli A; Sanguedolce F; Rodriguez-Faba Ó; Gaya JM; Palou J; Huguet J; Breda A
Actas Urol Esp (Engl Ed); 2023 May; 47(4):221-228. PubMed ID: 36379260
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
[TBL] [Abstract][Full Text] [Related]
25. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
Thalmann GN; Markwalder R; Walter B; Studer UE
J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
[TBL] [Abstract][Full Text] [Related]
27. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
Okubo K; Ishitoya S; Maeda H; Suzuki Y; Arai Y
Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861
[TBL] [Abstract][Full Text] [Related]
28. Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.
Kubota Y; Hatakeyama S; Tanaka T; Fujita N; Iwamura H; Mikami J; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Sasaki A; Kawaguchi T; Ohyama C
Oncotarget; 2017 Nov; 8(60):101500-101508. PubMed ID: 29254181
[TBL] [Abstract][Full Text] [Related]
29. Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.
Anan G; Hatakeyama S; Fujita N; Iwamura H; Tanaka T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Sato M; Ohyama C
Oncotarget; 2017 Oct; 8(49):86130-86142. PubMed ID: 29156782
[TBL] [Abstract][Full Text] [Related]
30. Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Kodama H; Hatakeyama S; Fujita N; Iwamura H; Anan G; Fukushi K; Narita T; Tanaka T; Kubota Y; Horiguchi H; Momota M; Kido K; Matsumoto T; Soma O; Hamano I; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Sasaki A; Kawaguchi T; Sato M; Ohyama C
Oncotarget; 2017 Oct; 8(47):83183-83194. PubMed ID: 29137333
[TBL] [Abstract][Full Text] [Related]
31. Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
Hamano I; Hatakeyama S; Iwamurau H; Fujita N; Fukushi K; Narita T; Hagiwara K; Kusaka A; Hosogoe S; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
Oncotarget; 2017 Sep; 8(37):61404-61414. PubMed ID: 28977873
[TBL] [Abstract][Full Text] [Related]
32. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
[TBL] [Abstract][Full Text] [Related]
33. Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
Kusaka A; Hatakeyama S; Hosogoe S; Hamano I; Iwamura H; Fujita N; Fukushi K; Narita T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
Med Oncol; 2017 May; 34(5):90. PubMed ID: 28397105
[TBL] [Abstract][Full Text] [Related]
34. A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.
Bellmunt J; Powles T; Vogelzang NJ
Cancer Treat Rev; 2017 Mar; 54():58-67. PubMed ID: 28214651
[TBL] [Abstract][Full Text] [Related]
35. Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction.
Redrow GP; Guo CC; Brausi MA; Coleman JA; Fernandez MI; Kassouf W; Keeley FX; Margulis V; Raman JD; Roupret M; Shariat SF; Spiess PE; Thalmann GN; Matin SF
J Urol; 2017 Feb; 197(2):287-295. PubMed ID: 27664578
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic Versus Open Nephroureterectomy in Muscle-Invasive Upper Tract Urothelial Carcinoma: Subanalysis of the Multi-Institutional National Database of the Japanese Urological Association.
Miyazaki J; Nishiyama H; Fujimoto H; Ohyama C; Koie T; Hinotsu S; Kikuchi E; Sakura M; Inokuchi J; Hara T
J Endourol; 2016 May; 30(5):520-5. PubMed ID: 26669358
[TBL] [Abstract][Full Text] [Related]
37. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.
Austin PC; Stuart EA
Stat Med; 2015 Dec; 34(28):3661-79. PubMed ID: 26238958
[TBL] [Abstract][Full Text] [Related]
38. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
39. Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary--Japanese Urological Association, 2014 edition).
Oya M; Kikuchi E; ;
Int J Urol; 2015 Jan; 22(1):3-13. PubMed ID: 25243652
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
